Magnoflorine Ameliorates Chronic Kidney Disease in High-Fat and High-Fructose-Fed Mice by Promoting Parkin/PINK1-Dependent Mitophagy to Inhibit NLRP3/Caspase-1-Mediated Pyroptosis-Reference-Cited by-同舟云学术

Magnoflorine Ameliorates Chronic Kidney Disease in High-Fat and High-Fructose-Fed Mice by Promoting Parkin/PINK1-Dependent Mitophagy to Inhibit NLRP3/Caspase-1-Mediated Pyroptosis

Published:2024-05-22 Issue:22 Volume:72 Page:12775-12787
ISSN:0021-8561
Container-title:Journal of Agricultural and Food Chemistry
language:en
Short-container-title:J. Agric. Food Chem.

Author:

Cheng Ye¹,Lu Zhengjie²,Mao Tongyun³,Song Yingying⁴,Qu Yaqin⁴,Chen Xin⁴,Chen Kaiqi⁵,Liu Kexin⁶,Zhang Cong⁷^ORCID

Affiliation:

1. Pharmaceutical Department, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, China

2. Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430072, China

3. Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China

4. Hubei Key Laboratory of Resources and Chemistry of Chinese Medicine, School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China

5. Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

6. Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan 430072, China

7. College of Basic Medical Sciences, China Three Gorges University, Yichang 443002, China

Funder

Natural Science Foundation of Hubei Province

National Natural Science Foundation of China

Hubei Key Laboratory of Resources and Chemistry of Chinese Medicine, Hubei University of Chinese Medicine

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jafc.3c09634

Reference48 articles.

1. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Chronic kidney disease: global dimension and perspectives

3. The global burden of chronic kidney disease: estimates, variability and pitfalls

4. Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease

5. Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function